Interesting that they included a comparison of responses based upon levels of breathlessness at outset of treatment
https://www.globenewswire.com/news-release/2021/04/30/2220373/0/en/Synairgen-announces-data-from-Home-Cohort-of-SG016-Phase-II-trial-of-inhaled-interferon-beta-in-COVID-19-patients-and-encouraging-combined-data-for-whole-SG016-trial.html